Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Daniel Johnathan HughesEleni JosephidesRobert O'SheaThubeena ManickavasagarCarolyn HorstSarah HunterPhilippe TanièreDaisuke NonakaMieke Van HemelrijckJames SpicerVicky GohAndrea BilleEleni KarapanagiotouDaniel Johnathan HughesPublished in: European radiology (2024)
F]FDG-PET/CT) metabolic parameters were significantly higher in primary tumour or lymph node metastases with positive programmed death-ligand 1 expression. • These SUV-based parameters could potentially play an additive role along with other multi-modal biomarkers in selecting patients within a predictive nomogram.
Keyphrases
- positron emission tomography
- pet ct
- computed tomography
- lymph node
- pet imaging
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- magnetic resonance imaging
- prognostic factors
- peritoneal dialysis
- dual energy
- neoadjuvant chemotherapy
- magnetic resonance
- early stage
- patient reported outcomes
- long non coding rna
- sentinel lymph node